Specificity and Dynamics of Effector and Memory CD8 T Cell Responses in Human Tick-Borne Encephalitis Virus Infection

被引:41
|
作者
Blom, Kim [1 ]
Braun, Monika [1 ]
Pakalniene, Jolita [2 ]
Dailidyte, Laura [2 ]
Beziat, Vivien [1 ,3 ]
Lampen, Margit H. [1 ]
Klingstrom, Jonas [1 ]
Lagerqvist, Nina [1 ]
Kjerstadius, Torbjorn [4 ]
Michaelsson, Jakob [1 ]
Lindquist, Lars [5 ,6 ]
Ljunggren, Hans-Gustaf [1 ]
Sandberg, Johan K. [1 ]
Mickiene, Aukse [2 ,6 ]
Gredmark-Russ, Sara [1 ,5 ]
机构
[1] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden
[2] Lithuanian Univ Hlth Sci, Dept Infect Dis, Kaunas, Lithuania
[3] INSERM, U1163, Imagine Inst, Human Genet Infect Dis Lab, Paris, France
[4] Karolinska Univ Hosp Solna, Dept Clin Microbiol, Karolinska Univ Lab, Stockholm, Sweden
[5] Karolinska Univ Hosp Huddinge, Dept Infect Dis, Stockholm, Sweden
[6] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Infect Dis Unit, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
LYME BORRELIOSIS; CLINICAL-COURSE; EPSTEIN-BARR; SUBSETS; BET; DIFFERENTIATION; EXPRESSION; PHENOTYPE; MICE; VISUALIZATION;
D O I
10.1371/journal.ppat.1004622
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Tick-borne encephalitis virus (TBEV) is transferred to humans by ticks. The virus causes tick-borne encephalitis (TBE) with symptoms such as meningitis and meningoencephalitis. About one third of the patients suffer from long-lasting sequelae after clearance of the infection. Studies of the immune response during TBEV-infection are essential to the understanding of host responses to TBEV-infection and for the development of therapeutics. Here, we studied in detail the primary CD8 T cell response to TBEV in patients with acute TBE. Peripheral blood CD8 T cells mounted a considerable response to TBEV-infection as assessed by Ki67 and CD38 co-expression. These activated cells showed a CD45RA-CCR7-CD127-phenotype at day 7 after hospitalization, phenotypically defining them as effector cells. An immunodominant HLA-A2-restricted TBEV epitope was identified and utilized to study the characteristics and temporal dynamics of the antigen-specific response. The functional profile of TBEV-specific CD8 T cells was dominated by variants of monofunctional cells as the effector response matured. Antigen-specific CD8 T cells predominantly displayed a distinct Eomes+Ki67+T-bet+ effector phenotype at the peak of the response, which transitioned to an Eomes-Ki67-T-bet+ phenotype as the infection resolved and memory was established. These transcription factors thus characterize and discriminate stages of the antigen-specific T cell response during acute TBEV-infection. Altogether, CD8 T cells responded strongly to acute TBEV infection and passed through an effector phase, prior to gradual differentiation into memory cells with distinct transcription factor expression- patterns throughout the different phases.
引用
收藏
页码:1 / 20
页数:20
相关论文
共 50 条
  • [31] MicroRNA miR-155 Affects Antiviral Effector and Effector Memory CD8 T Cell Differentiation
    Tsai, Ching-Yi
    Allie, S. Rameeza
    Zhang, Weijun
    Usherwood, Edward J.
    JOURNAL OF VIROLOGY, 2013, 87 (04) : 2348 - 2351
  • [32] Tick-borne encephalitis virus modulates sphingolipid and phospholipid metabolism in infected human neuronal cells
    Simeckova, Pavlina
    Slavik, Josef
    Fortova, Andrea
    Huvarova, Ivana
    Kralikova, Lucie
    Stefanik, Michal
    Svoboda, Pavel
    Ruzek, Daniel
    Machala, Miroslav
    MICROBES AND INFECTION, 2024, 26 (04)
  • [33] Differential Regulation of Primary and Memory CD8 T Cell Immune Responses by Diacylglycerol Kinases
    Shin, Jinwook
    O'Brien, Thomas F.
    Grayson, Jason M.
    Zhong, Xiao-Ping
    JOURNAL OF IMMUNOLOGY, 2012, 188 (05) : 2111 - 2117
  • [34] Early Mortality Following Intracerebral Infection with the Oshima Strain of Tick-Borne Encephalitis Virus in a Mouse Model
    Hayasaka, Daisuke
    Nagata, Noriyo
    Hasegawa, Hideki
    Sata, Tetsutaro
    Takashima, Ikuo
    Koike, Satoshi
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2010, 72 (04) : 391 - 396
  • [35] Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity
    Molodtsov, Aleksey
    Turk, Mary Jo
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [36] Effector CD8 T cells dedifferentiate into long-lived memory cells
    Youngblood, Ben
    Hale, J. Scott
    Kissick, Haydn T.
    Ahn, Eunseon
    Xu, Xiaojin
    Wieland, Andreas
    Araki, Koichi
    West, Erin E.
    Ghoneim, Hazem E.
    Fan, Yiping
    Dogra, Pranay
    Davis, Carl W.
    Konieczny, Bogumila T.
    Antia, Rustom
    Cheng, Xiaodong
    Ahmed, Rafi
    NATURE, 2017, 552 (7685) : 404 - +
  • [37] Dynamics and Correlates of CD8 T-Cell Counts in Africans with Primary Human Immunodeficiency Virus Type 1 Infection
    Prentice, Heather A.
    Lu, Hailin
    Price, Matthew A.
    Kamali, Anatoli
    Karita, Etienne
    Lakhi, Shabir
    Sanders, Eduard J.
    Anzala, Omu
    Allen, Susan
    Goepfert, Paul A.
    Hunter, Eric
    Gilmour, Jill
    Tang, Jianming
    JOURNAL OF VIROLOGY, 2016, 90 (22) : 10423 - 10430
  • [38] Batf3-Dependent Dendritic Cells Promote Optimal CD8 T Cell Responses against Respiratory Poxvirus Infection
    Desai, Pritesh
    Tahiliani, Vikas
    Abboud, Georges
    Stanfield, Jessica
    Salek-Ardakani, Shahram
    JOURNAL OF VIROLOGY, 2018, 92 (16)
  • [39] Changes in cytokine and chemokine profiles in mouse serum and brain, and in human neural cells, upon tick-borne encephalitis virus infection
    Formanova, Petra Pokorna
    Palus, Martin
    Salat, Jiri
    Honig, Vaclav
    Stefanik, Michal
    Svoboda, Pavel
    Ruzek, Daniel
    JOURNAL OF NEUROINFLAMMATION, 2019, 16 (01)
  • [40] Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins
    Aregay, Amare
    Slunecko, Jan
    Korva, Misa
    Bogovic, Petra
    Resman Rus, Katarina
    Knap, Natasa
    Beicht, Jana
    Kubinski, Mareike
    Saletti, Giulietta
    Avsic-Zupanc, Tatjana
    Steffen, Imke
    Strle, Franc
    Osterhaus, Albert D. M. E.
    Rimmelzwaan, Guus F.
    NPJ VACCINES, 2024, 9 (01)